Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

rosuvastatin

rosuvastatin
  • Restricted HMG CoA Reductase Inhibitor Formulary
  • Restricted Crestor --> Restricted to NO SUB orders.
  • Restricted Ezallor Sprinkle--> Restricted to pediatric patients.
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Ezallor Sprinkle CAPSULE, ORAL 5 mg, 10 mg, 20 mg, 40 mg    
Crestor TABLET, ORAL 5 mg, 10 mg, 20 mg, 40 mg    
VIEW MORE HMG-CoA Reductase Inhibitors
CLASS
240608
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

rosuvastatin (Crestor)

  • 5 mg tablet oral
  • 10 mg tablet oral
  • 20 mg tablet oral
  • 40 mg tablet oral

atorvaSTATin (Lipitor)

  • 10 mg tablet oral
  • 20 mg tablet oral
  • 40 mg tablet oral
  • 80 mg tablet oral

Ezallor Sprinkle is formulary restricted to pediatric patients unable to swallow tablets and/or with a nasogastric tube requiring statin therapy. 

For adults, formulary statin tablet, atorvastatin, will be crushed.

Reviewed: February 27, 2007 and July 28, 2009,  October 22, 2013, and July 2020 (Ezallor Sprinkle)

Last updated: Dec. 22, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved